| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphoprotein binding | 2.26e-04 | 117 | 51 | 4 | GO:0051219 | |
| GeneOntologyMolecularFunction | potassium channel inhibitor activity | 3.47e-04 | 11 | 51 | 2 | GO:0019870 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 8.85e-05 | 96 | 51 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 2.76e-04 | 129 | 51 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | Ino80 complex | 7.75e-04 | 17 | 51 | 2 | GO:0031011 | |
| Domain | NACHT | 3.27e-05 | 23 | 51 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 3.27e-05 | 23 | 51 | 3 | IPR007111 | |
| Domain | - | 1.20e-04 | 93 | 51 | 4 | 1.10.533.10 | |
| Domain | DEATH-like_dom | 1.53e-04 | 99 | 51 | 4 | IPR011029 | |
| Domain | DAPIN | 1.63e-03 | 22 | 51 | 2 | PS50824 | |
| Domain | DAPIN | 1.63e-03 | 22 | 51 | 2 | IPR004020 | |
| Domain | PYRIN | 1.63e-03 | 22 | 51 | 2 | SM01289 | |
| Domain | PYRIN | 1.63e-03 | 22 | 51 | 2 | PF02758 | |
| Domain | LRR_6 | 9.90e-03 | 55 | 51 | 2 | PF13516 | |
| Domain | SH3_1 | 1.02e-02 | 164 | 51 | 3 | PF00018 | |
| Domain | VWA | 1.02e-02 | 56 | 51 | 2 | PF00092 | |
| Domain | C1_1 | 1.06e-02 | 57 | 51 | 2 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 1.32e-02 | 64 | 51 | 2 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.32e-02 | 64 | 51 | 2 | PS50081 | |
| Pubmed | RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner. | 2.11e-06 | 2 | 51 | 2 | 34065204 | |
| Pubmed | [Interaction of two tumor suppressors: Phosphatase CTDSPL and Rb protein]. | 2.11e-06 | 2 | 51 | 2 | 27414789 | |
| Pubmed | RBEL1 is required for osteosarcoma cell proliferation via inhibiting retinoblastoma 1. | 2.11e-06 | 2 | 51 | 2 | 26676380 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 25273089 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 34096602 | ||
| Pubmed | Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production. | 6.32e-06 | 3 | 51 | 2 | 15907217 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 27458253 | ||
| Pubmed | 8.77e-06 | 330 | 51 | 6 | 32529326 | ||
| Pubmed | A molecular link between SR protein dephosphorylation and mRNA export. | 1.26e-05 | 4 | 51 | 2 | 15210956 | |
| Pubmed | Hypophosphorylated ASF/SF2 binds TAP and is present in messenger ribonucleoproteins. | 1.26e-05 | 4 | 51 | 2 | 15184380 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 11246230 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 15123677 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 33602301 | ||
| Pubmed | CircCDR1as mediates PM2.5-induced lung cancer progression by binding to SRSF1. | 2.10e-05 | 5 | 51 | 2 | 36508830 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 25416801 | ||
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 20808760 | ||
| Pubmed | Srsf10 and the minor spliceosome control tissue-specific and dynamic SR protein expression. | 4.41e-05 | 7 | 51 | 2 | 32338600 | |
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 35194031 | ||
| Pubmed | Caspase-9 can antagonize p53-induced apoptosis by generating a p76(Rb) truncated form of Rb. | 5.87e-05 | 8 | 51 | 2 | 15735701 | |
| Pubmed | Expression patterns of novel genes during mouse preimplantation embryogenesis. | 5.87e-05 | 8 | 51 | 2 | 7545925 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 6.66e-05 | 695 | 51 | 7 | 23602568 | |
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 19857271 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 9.52e-05 | 736 | 51 | 7 | 29676528 | |
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 20598684 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 26611327 | ||
| Pubmed | NODs: intracellular proteins involved in inflammation and apoptosis. | 1.38e-04 | 12 | 51 | 2 | 12766759 | |
| Pubmed | 1.40e-04 | 179 | 51 | 4 | 19074885 | ||
| Pubmed | A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). | 1.63e-04 | 13 | 51 | 2 | 20516191 | |
| Pubmed | 1.72e-04 | 73 | 51 | 3 | 22094256 | ||
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 20403135 | ||
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 12563287 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | 2.15e-04 | 1124 | 51 | 8 | 21900206 | |
| Pubmed | 2.19e-04 | 15 | 51 | 2 | 11085536 | ||
| Pubmed | Ki-1/57 interacts with PRMT1 and is a substrate for arginine methylation. | 2.19e-04 | 15 | 51 | 2 | 16879614 | |
| Pubmed | Transcriptional activators differ in their abilities to control alternative splicing. | 2.50e-04 | 16 | 51 | 2 | 12221105 | |
| Pubmed | LncRNA ANCR promotes hepatocellular carcinoma metastasis through upregulating HNRNPA1 expression. | 2.83e-04 | 17 | 51 | 2 | 31868085 | |
| Pubmed | 3.94e-04 | 425 | 51 | 5 | 24999758 | ||
| Pubmed | 3.94e-04 | 425 | 51 | 5 | 21081503 | ||
| Pubmed | Recruitment of the human TREX complex to mRNA during splicing. | 3.94e-04 | 20 | 51 | 2 | 15998806 | |
| Pubmed | 3.94e-04 | 20 | 51 | 2 | 33995658 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 4.07e-04 | 934 | 51 | 7 | 33916271 | |
| Pubmed | 4.42e-04 | 242 | 51 | 4 | 34011540 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 4.62e-04 | 954 | 51 | 7 | 36373674 | |
| Pubmed | 4.87e-04 | 104 | 51 | 3 | 9205841 | ||
| Pubmed | 5.14e-04 | 971 | 51 | 7 | 33306668 | ||
| Pubmed | 5.70e-04 | 24 | 51 | 2 | 20624904 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 5.75e-04 | 462 | 51 | 5 | 31138677 | |
| Pubmed | 5.81e-04 | 463 | 51 | 5 | 27503909 | ||
| Pubmed | 5.98e-04 | 713 | 51 | 6 | 29802200 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 6.52e-04 | 475 | 51 | 5 | 31040226 | |
| Pubmed | 6.90e-04 | 733 | 51 | 6 | 34672954 | ||
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | 6.91e-04 | 1021 | 51 | 7 | 26760575 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 7.61e-04 | 1038 | 51 | 7 | 26673895 | |
| Pubmed | 7.78e-04 | 28 | 51 | 2 | 18067320 | ||
| Pubmed | 7.98e-04 | 497 | 51 | 5 | 23414517 | ||
| Pubmed | 8.47e-04 | 288 | 51 | 4 | 23383273 | ||
| Pubmed | 8.65e-04 | 506 | 51 | 5 | 30890647 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 9.15e-04 | 774 | 51 | 6 | 15302935 | |
| Pubmed | 9.81e-04 | 1084 | 51 | 7 | 11544199 | ||
| Pubmed | Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation. | 1.02e-03 | 134 | 51 | 3 | 28695742 | |
| Pubmed | 1.05e-03 | 1429 | 51 | 8 | 35140242 | ||
| Pubmed | 1.09e-03 | 533 | 51 | 5 | 25544563 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.10e-03 | 1105 | 51 | 7 | 35748872 | |
| Pubmed | The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myeloma. | 1.15e-03 | 34 | 51 | 2 | 36059274 | |
| Pubmed | 1.21e-03 | 317 | 51 | 4 | 30997501 | ||
| Pubmed | 1.22e-03 | 547 | 51 | 5 | 37267103 | ||
| Pubmed | 1.24e-03 | 549 | 51 | 5 | 38280479 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 1.37e-03 | 1489 | 51 | 8 | 28611215 | |
| Pubmed | MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. | 1.41e-03 | 150 | 51 | 3 | 22678362 | |
| Pubmed | 1.41e-03 | 1497 | 51 | 8 | 31527615 | ||
| Pubmed | Lysine acetylation targets protein complexes and co-regulates major cellular functions. | 1.43e-03 | 38 | 51 | 2 | 19608861 | |
| Cytoband | 3p21.3 | 4.02e-05 | 59 | 51 | 3 | 3p21.3 | |
| GeneFamily | NLR family | 1.48e-05 | 25 | 35 | 3 | 666 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 2.37e-04 | 12 | 35 | 2 | 737 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 1.06e-03 | 25 | 35 | 2 | 994 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.30e-03 | 206 | 35 | 3 | 682 | |
| GeneFamily | RNA binding motif containing | 8.00e-03 | 213 | 35 | 3 | 725 | |
| GeneFamily | SH2 domain containing | 1.63e-02 | 101 | 35 | 2 | 741 | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | 4.50e-06 | 193 | 51 | 6 | 6730_UP | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 4.64e-06 | 194 | 51 | 6 | 2900_DN | |
| Drug | Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 4.78e-06 | 195 | 51 | 6 | 2290_DN | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; PC3; HT_HG-U133A | 4.92e-06 | 196 | 51 | 6 | 5084_UP | |
| Drug | Dichlorphenamide [120-97-8]; Down 200; 13.2uM; PC3; HT_HG-U133A | 5.06e-06 | 197 | 51 | 6 | 6686_DN | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 5.37e-06 | 199 | 51 | 6 | 5471_UP | |
| Drug | YF-1 | 3.60e-05 | 83 | 51 | 4 | CID000445779 | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; HL60; HT_HG-U133A | 6.77e-05 | 191 | 51 | 5 | 6142_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A | 6.94e-05 | 192 | 51 | 5 | 5216_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 6868_DN | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; PC3; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 5724_DN | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; PC3; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 7320_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 2783_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 2641_DN | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; PC3; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 6725_UP | |
| Drug | Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; PC3; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 2082_DN | |
| Drug | probucol; Down 200; 10uM; MCF7; HG-U133A | 8.03e-05 | 198 | 51 | 5 | 592_DN | |
| Drug | Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; PC3; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 4684_UP | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; PC3; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 6349_UP | |
| Drug | (cis-) Nanophine [5072-45-7]; Up 200; 26.8uM; PC3; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 4543_UP | |
| Drug | Skimmianine [83-95-4]; Up 200; 15.4uM; PC3; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 5766_UP | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 3780_DN | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; PC3; HT_HG-U133A | 8.42e-05 | 200 | 51 | 5 | 4006_UP | |
| Disease | Mental Retardation, Psychosocial | 1.31e-07 | 139 | 50 | 6 | C0025363 | |
| Disease | Profound Mental Retardation | 1.31e-07 | 139 | 50 | 6 | C0020796 | |
| Disease | Mental deficiency | 1.31e-07 | 139 | 50 | 6 | C0917816 | |
| Disease | Intellectual Disability | 9.95e-06 | 447 | 50 | 7 | C3714756 | |
| Disease | Neoplasm Metastasis | 5.03e-04 | 217 | 50 | 4 | C0027627 | |
| Disease | Sarcoma | 5.79e-04 | 21 | 50 | 2 | C1261473 | |
| Disease | chronic myeloid leukemia (is_marker_for) | 9.61e-04 | 27 | 50 | 2 | DOID:8552 (is_marker_for) | |
| Disease | Pigmented Basal Cell Carcinoma | 1.03e-03 | 28 | 50 | 2 | C1368275 | |
| Disease | Carcinoma, Basal Cell | 1.11e-03 | 29 | 50 | 2 | C4721806 | |
| Disease | clear cell renal cell carcinoma (is_marker_for) | 1.44e-03 | 33 | 50 | 2 | DOID:4467 (is_marker_for) | |
| Disease | obsolete_red blood cell distribution width | 1.80e-03 | 1347 | 50 | 8 | EFO_0005192 | |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 2.32e-03 | 42 | 50 | 2 | DOID:8991 (is_marker_for) | |
| Disease | squamous cell lung carcinoma | 2.78e-03 | 165 | 50 | 3 | EFO_0000708 | |
| Disease | Small cell carcinoma of lung | 3.81e-03 | 54 | 50 | 2 | C0149925 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FREPVTLDFLDAELE | 571 | Q9NY47 | |
| EDTDFLEDPDFLEAI | 101 | P51861 | |
| RTAFRLPDFEIEELE | 31 | Q9BXF3 | |
| RLERFFDSEDEDFEI | 376 | Q9Y4P1 | |
| LNSIFFELEADEREP | 416 | P01019 | |
| RLEFEETEEPDFTAL | 46 | P06400 | |
| EFVFDDLPPDINRFE | 641 | P20936 | |
| EDFVPDDRLDRSFLE | 391 | Q3YEC7 | |
| RFDQLFDDESDPFEV | 16 | Q8NC51 | |
| LDFDPDIVAALDDDF | 136 | Q96GA3 | |
| DFDDPDNLLEDDFIL | 151 | Q96GA3 | |
| DLLEDPEIFFDVVSL | 41 | Q6P4R8 | |
| FILDGFDELQRPFEE | 246 | Q86W26 | |
| DLRFIPDDITFDDEP | 466 | Q9H501 | |
| FFDLENLLDPDARVD | 141 | P38570 | |
| NVLELIEFFEEEDRF | 141 | Q9HBH9 | |
| SRFFPEAIEFIDEAL | 266 | Q99956 | |
| PERDPEEVFAFLLRF | 261 | Q9Y239 | |
| FFLDPSDLDVERDEE | 371 | O94806 | |
| IILASDVFFEPEDFE | 96 | Q86XA0 | |
| DVFFEPEDFEDILAT | 101 | Q86XA0 | |
| RFERFDREDDLIIEF | 2481 | Q7Z6Z7 | |
| EKYQELLEREDFFPD | 421 | Q9H074 | |
| QREDFEPFVEDDIPF | 106 | Q5T2D3 | |
| ELFEEPFVADEYIER | 6 | O00471 | |
| EEELDFFEILRLFFP | 176 | Q9UIV1 | |
| NLELIFDFFEEDLSE | 226 | Q9NPB8 | |
| PEDELEEIREAFKVF | 31 | Q86V35 | |
| LDLIPFFEGLSREDD | 251 | O15194 | |
| EDLEEANPFSFREFL | 101 | Q96C92 | |
| FLEDLDEPDTEDFRT | 561 | Q3T8J9 | |
| PPLREFFVDDFEELL | 271 | Q9Y2E4 | |
| LFELARDLEEEFVYE | 351 | Q12894 | |
| LFAEFFRDLDIVPSD | 221 | Q9Y4D2 | |
| LAEDLLSEEDPFFLA | 66 | Q92851 | |
| RVFRDFDFLDVELED | 2456 | Q5TBA9 | |
| LLDRFDYDDEPEAVE | 261 | O95104 | |
| IDLLERLAEDTPFDF | 481 | O60391 | |
| PFADIFDEDETERNF | 11 | Q5TCS8 | |
| DDEEDEELPRFILHY | 371 | Q5H9M0 | |
| EEEAENFAPILAFLD | 461 | Q8TF17 | |
| KLNPVELFELFFDDE | 416 | Q96JS3 | |
| FLFLNPDDFLDDEDE | 426 | Q76KP1 | |
| FLERFPELEAEDIFD | 286 | Q96JQ2 | |
| SEVDFEERFAELPEF | 1351 | Q96RK0 | |
| EERFAELPEFRPEEV | 1356 | Q96RK0 | |
| FVEFEDPRDAEDAVR | 51 | Q16629 | |
| DQEEEPLERDFDRFI | 106 | Q8TDP1 | |
| LRPDFFDSAAIIEDD | 1236 | Q8WVM7 | |
| FSPEFEFEEEFSRDR | 286 | Q53FD0 | |
| FAFVEFEDPRDAEDA | 56 | Q07955 | |
| SELFDPFDLFDVRDF | 91 | P52735 | |
| AIEFSFDLERDVPED | 521 | Q9H4A3 | |
| FDELNFAFEEPEFAL | 261 | Q86W24 |